The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
New agents for the treatment of infections with Gram-negative bacteria: restoring the miracle or false dawn?
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,044
Falagas, M. E., Vouloumanou, E. K., Samonis, G., & Vardakas, K. Z. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00068-15 · Cited by 612
Avibactam is a covalent, reversible, non–β-lactam β-lactamase inhibitor
Ehmann, D. E., Jahić, H., Ross, P. L., Gu, R.-F., Hu, J., Kern, G., Walkup, G. K., & Fisher, S. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205073109 · Cited by 545
Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections
Falagas, M. E., Tansarli, G. S., Karageorgopoulos, D. E., & Vardakas, K. Z. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2007.121004 · Cited by 514
Shields, R. K., Nguyen, M. H., Chen, L., Press, E. G., Potoski, B. A., Marini, R. V., Doi, Y., Kreiswirth, B. N., & Clancy, C. J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00883-17 · Cited by 495
Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination
Zhanel, G. G., Lawson, C. D., Adam, H., Schweizer, F., Zelenitsky, S., Lagacé-Wiens, P. R. S., Denisuik, A., Rubinstein, E., Gin, A. S., Hoban, D. J., et al. (2013) · Drugs · doi:10.1007/s40265-013-0013-7 · Cited by 433
Shields, R. K., Potoski, B. A., Haidar, G., Hao, B., Doi, Y., Chen, L., Press, E. G., Kreiswirth, B. N., Clancy, C. J., & Nguyen, M. H. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw636 · Cited by 430
Hecker, S. J., Reddy, K. R., Totrov, M., Hirst, G. C., Lomovskaya, O., Griffith, D. C., King, P., Tsivkovski, R., Sun, D., Sabet, M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00127 · Cited by 422
Solomkin, J., Hershberger, E., Miller, B., Popejoy, M., Friedland, I., Steenbergen, J., Yoon, M., Collins, S., Yuan, G., Barie, P. S., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ097 · Cited by 420
Carmeli, Y., Armstrong, J., Laud, P. J., Newell, P., Stone, G., Wardman, A., & Gasink, L. B. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30004-4 · Cited by 417
Mazuski, J. E., Gasink, L. B., Armstrong, J., Broadhurst, H., Stone, G. G., Rank, D., Llorens, L., Newell, P., & Pachl, J. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw133 · Cited by 393
Wagenlehner, F. M., Umeh, O., Steenbergen, J., Yuan, G., & Darouiche, R. O. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62220-0 · Cited by 388
Wagenlehner, F. M., Sobel, J. D., Newell, P., Armstrong, J., Huang, X., Stone, G. G., Yates, K., & Gasink, L. B. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw378 · Cited by 362
Zhanel, G. G., Chung, P., Adam, H., Zelenitsky, S., Denisuik, A., Schweizer, F., Lagacé-Wiens, P. R. S., Rubinstein, E., Gin, A. S., Walkty, A., et al. (2014) · Drugs · doi:10.1007/s40265-013-0168-2 · Cited by 340
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
Zhanel, G. G., Cheung, D., Adam, H., Zelenitsky, S., Golden, A., Schweizer, F., Gorityala, B., Lagacé-Wiens, P. R. S., Walkty, A., Gin, A. S., et al. (2016) · Drugs · doi:10.1007/s40265-016-0545-8 · Cited by 317
Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials
Prasad, P., Sun, J., Danner, R. L., & Natanson, C. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis270 · Cited by 298
Jacoby, G. A., & Han, P. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.4.908-911.1996 · Cited by 295
Marshall, S., Hujer, A. M., Rojas, L. J., Papp-Wallace, K. M., Humphries, R. M., Spellberg, B., Hujer, K. M., Marshall, E. K., Rudin, S. D., Perez, F., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02243-16 · Cited by 293
Self-citationNew β-Lactamase Inhibitors: a Therapeutic Renaissance in an MDR World
Drawz, S. M., Papp-Wallace, K. M., & Bonomo, R. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00826-13 · Cited by 286
Self-citationSolomkin, J., Evans, D., Slepavicius, A., Lee, P., Marsh, A., Tsai, L., Sutcliffe, J. A., & Horn, P. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2016.4237 · Cited by 276
Siderophores as drug delivery agents: application of the “Trojan Horse” strategy
Möllmann, U., Heinisch, L., Bauernfeind, A., Köhler, T., & Ankel-Fuchs, D. (2009) · BioMetals · doi:10.1007/s10534-009-9219-2 · Cited by 274
Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa
Livermore, D. M., Warner, M., & Mushtaq, S. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt178 · Cited by 268
Dosing guidance for intravenous colistin in critically-ill patients.
Nation, R. L., Garonzik, S. M., Thamlikitkul, V., Giamarellos-Bourboulis, E. J., Forrest, A., Paterson, D. L., Li, J., & Silveira, F. P. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw839 · Cited by 262
Self-citationFirst Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate
Humphries, R. M., Yang, S., Hemarajata, P., Ward, K. W., Hindler, J. A., Miller, S. A., & Gregson, A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01165-15 · Cited by 255
Cabot, G., Bruchmann, S., Mulet, X., Zamorano, L., Moyà, B., Juan, C., Haussler, S., & Oliver, A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02462-13 · Cited by 247
Kohira, N., West, J., Ito, A., Ito-Horiyama, T., Nakamura, R., Sato, T., Rittenhouse, S., Tsuji, M., & Yamano, Y. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01695-15 · Cited by 247
Synthesis and Spectrum of the Neoglycoside ACHN-490
Aggen, J. B., Armstrong, E. S., Goldblum, A. A., Dozzo, P., Linsell, M. S., Gliedt, M. J., Hildebrandt, D. J., Feeney, L. A., Kubo, A., Matias, R. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00572-10 · Cited by 243
Sutcliffe, J. A., O'Brien, W., Fyfe, C., & Grossman, T. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01288-13 · Cited by 235
Page, M. G. P., Dantier, C., & Desarbre, E. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01525-09 · Cited by 227
Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria
Falagas, M. E., Bliziotis, I. A., Kasiakou, S. K., Samonis, G., Athanassopoulou, P., & Michalopoulos, A. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-24 · Cited by 224
Ito, A., Kohira, N., Bouchillon, S. K., West, J., Rittenhouse, S., Sader, H. S., Rhomberg, P. R., Jones, R. N., Yoshizawa, H., Nakamura, R., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv402 · Cited by 192
Bush, K. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.08.011 · Cited by 188
Carbapenem-Resistant Strain of Klebsiellaoxytoca Harboring Carbapenem-Hydrolyzingβ-LactamaseKPC-2
Yigit, H., Queenan, A. M., Rasheed, J. K., Biddle, J. W., Domenech-Sanchez, A., Alberti, S., Bush, K., & Tenover, F. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3881-3889.2003 · Cited by 187
Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases
Ito-Horiyama, T., Ishii, Y., Ito, A., Sato, T., Nakamura, R., Fukuhara, N., Tsuji, M., Yamano, Y., Yamaguchi, K., & Tateda, K. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03098-15 · Cited by 187
Lucasti, C., Vasile, L., Sandesc, D., Venskutonis, D., McLeroth, P., Lala, M., Rizk, M. L., Brown, M. L., Losada, M. C., Pedley, A., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00633-16 · Cited by 182
Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York City
Lapuebla, A., Abdallah, M., Olafisoye, O., Cortes, C., Urban, C., Landman, D., & Quale, J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00830-15 · Cited by 181
Aktaş, Z., Kayacan, C., & Oncul, O. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.09.012 · Cited by 169
Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?
Nation, R. L., Garonzik, S. M., Li, J., Thamlikitkul, V., Giamarellos-Bourboulis, E. J., Paterson, D. L., Turnidge, J. D., Forrest, A., & Silveira, F. P. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ964 · Cited by 168
Self-citationTarget- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic
Grossman, T. H., Starosta, A. L., Fyfe, C., O'Brien, W., Rothstein, D. M., Mikolajka, A., Wilson, D. N., & Sutcliffe, J. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06187-11 · Cited by 162
Livermore, D. M., Mushtaq, S., Warner, M., & Woodford, N. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00436-16 · Cited by 152
Sader, H. S., Farrell, D. J., Castanheira, M., Flamm, R. K., & Jones, R. N. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku184 · Cited by 149
Lapuebla, A., Abdallah, M., Olafisoye, O., Cortes, C. D., Urban, C. M., Quale, J. M., & Landman, D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00843-15 · Cited by 147
Abdallah, M., Olafisoye, O., Cortes, C. D., Urban, C. M., Landman, D., & Quale, J. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04809-14 · Cited by 144
Munita, J. M., Aitken, S. L., Miller, W. R., Pérez, F., Rosa, R. M., Shimose, L. A., Lichtenberger, P. K., Abbo, L. M., Jain, R., Nigo, M., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix014 · Cited by 142
Self-citationBiedenbach, D. J., Kazmierczak, K. M., Bouchillon, S. K., Sahm, D. F., & Bradford, P. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00206-15 · Cited by 141
In Vitro and In Vivo Activities of a New Cephalosporin, FR264205, against Pseudomonas aeruginosa
Takeda, S., Nakai, T., Wakai, Y., Ikeda, F., & Hatano, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00860-06 · Cited by 140
Thaden, J. T., Pogue, J. M., & Kaye, K. S. (2016) · Virulence · doi:10.1080/21505594.2016.1207834 · Cited by 134
Li, H., Estabrook, M. A., Jacoby, G. A., Nichols, W. W., TESTA, R. T., & Bush, K. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04191-14 · Cited by 130
Popejoy, M. W., Paterson, D. L., Cloutier, D. J., Huntington, J. A., Miller, B. W., Bliss, C. A., Steenbergen, J. N., Hershberger, E., Umeh, O., & Kaye, K. S. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw374 · Cited by 129
Self-citationSader, H. S., Rhomberg, P. R., Farrell, D. J., & Jones, R. N. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01737-10 · Cited by 123
Castanheira, M., Mills, J. C., Costello, S. E., Jones, R. N., & Sader, H. S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00163-15 · Cited by 123
Walkty, A. J., Adam, H. J., Baxter, M. R., Denisuik, A. J., Lagacé-Wiens, P. R. S., Karlowsky, J. A., Hoban, D. J., & Zhanel, G. G. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02744-13 · Cited by 116
Kazmierczak, K. M., Biedenbach, D. J., Hackel, M., Rabine, S., DeJonge, B. L. M., Bouchillon, S. K., Sahm, D. F., & Bradford, P. A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00107-16 · Cited by 113
Sader, H. S., Rhomberg, P. R., Flamm, R. K., Jones, R. N., & Castanheira, M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx050 · Cited by 110
Levasseur, P., Girard, A.-M., Claudon, M., Goossens, H., Black, M. T., Coleman, K., & Miossec, C. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06064-11 · Cited by 102
Pfaller, M. A., Bassetti, M., Duncan, L. R., & Castanheira, M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx009 · Cited by 97
Galani, I., Souli, M., Daikos, G. L., Chryssouli, Z., Poulakou, G., Psichogiou, M., Panagea, T., Argyropoulou, A., Stefanou, I., Plakias, G., et al. (2012) · Journal of Chemotherapy · doi:10.1179/1973947812y.0000000015 · Cited by 96
Livermore, D. M., & Mushtaq, S. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt118 · Cited by 90
Sader, H. S., Castanheira, M., Flamm, R. K., Mendes, R. E., Farrell, D. J., & Jones, R. N. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.02.022 · Cited by 89
Wang, X., Zhang, F., Zhao, C., Wang, Z., Nichols, W. W., TESTA, R. T., Li, H., Chen, H., He, W., Wang, Q., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02123-13 · Cited by 88
Sader, H. S., Castanheira, M., Mendes, R. E., Flamm, R. K., Farrell, D. J., & Jones, R. N. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05024-14 · Cited by 83
Mojica, M. F., Ouellette, C. P., Leber, A. L., Becknell, B., Ardura, M. I., Pérez, F., Shimamura, M., Bonomo, R. A., Aitken, S. L., & Shelburne, S. A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00264-16 · Cited by 80
Self-citationShen, F., Han, Q., Xie, D., Fang, M., Zeng, H., & Deng, Y. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.08.009 · Cited by 76
The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?
Falagas, M. E., Mavroudis, A. D., & Vardakas, K. Z. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1204911 · Cited by 75
Bush, K., & Page, M. G. P. (2017) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-017-9506-4 · Cited by 73
Sonnevend, Á., Ghazawi, A., Hashmey, R., Haidermota, A., Girgis, S., Alfaresi, M. S., Omar, M., Paterson, D. L., Zowawi, H. M., & Pál, T. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00418-17 · Cited by 70
Self-citationWalkty, A. J., DeCorby, M. R., Lagacé-Wiens, P. R. S., Karlowsky, J. A., Hoban, D. J., & Zhanel, G. G. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01696-10 · Cited by 65
Karageorgopoulos, D. E., Miriagou, V., TZOUVELEKIS, L. S., Spyridopoulou, K., & Daikos, G. L. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks270 · Cited by 60
Huntington, J. A., Sakoulas, G., Umeh, O., Cloutier, D. J., Steenbergen, J. N., Bliss, C. A., & Goldstein, E. J. C. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw053 · Cited by 60
Zhang, Y., Lin, X., & Bush, K. (2016) · The Journal of Antibiotics · doi:10.1038/ja.2016.73 · Cited by 56
Eravacycline for the treatment of intra-abdominal infections
Bassetti, M., & Righi, E. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.965253 · Cited by 54
Flamm, R. K., Sader, H. S., Farrell, D. J., & Jones, R. N. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.07.005 · Cited by 50
Höfer, B., Dantier, C., Gebhardt, K., Desarbre, E., Schmitt‐Hoffmann, A. H., & Page, M. G. P. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks527 · Cited by 39
Mushtaq, S., Woodford, N., Hope, R., Adkin, R., & Livermore, D. M. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt050 · Cited by 37
Sader, H. S., Castanheira, M., Farrell, D. J., Flamm, R. K., & Jones, R. N. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.06.008 · Cited by 34
Estabrook, M. A., Bussell, B., Clugston, S. L., & Bush, K. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02357-14 · Cited by 26
Portsmouth, S., van Veenhuyzen, D., ECHOLS, R. M., et al. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx163.1399 · Cited by 26
Metamorphosis of Galleria mellonella research
Eisenman, H. C. (2015) · Virulence · doi:10.1080/21505594.2014.998541 · Cited by 17
Cited by
Horcajada, J. P., Montero, M., Oliver, A., Sorlí, L., Luque, S., Gómez-Zorrilla, S., Benito, N., & Grau, S. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00031-19 · Cited by 961
How to manage Pseudomonas aeruginosa infections
Bassetti, M., Vena, A., Croxatto, A., Righi, E., & Guery, B. (2018) · Drugs in Context · doi:10.7573/dic.212527 · Cited by 746
Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options
Sheu, C.-C., Chang, Y.-T., Lin, S.-Y., Chen, Y.-H., & Hsueh, P.-R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00080 · Cited by 520
Treatment of Infections Due to MDR Gram-Negative Bacteria
Bassetti, M., Peghin, M., Vena, A., & Giacobbe, D. R. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00074 · Cited by 326
Amikacin: Uses, Resistance, and Prospects for Inhibition
Ramirez, M., & Tolmasky, M. (2017) · Molecules · doi:10.3390/molecules22122267 · Cited by 265
Metadata
- Authors
- Wright, H., Bonomo, R. A., & Paterson, D. L.
- Venue
- Clinical Microbiology and Infection
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 23
- Issue
- 10
- Pages
- 704-712
- ISSN
- 1198-743X (ISSN-L)
- OpenAlex
- W2751939257
- Cited by
- 256
- References
- 78
- FWCI
- 14.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.